Akili, Inc.
NASDAQ: AKLI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Matthew Franklin
- Employees
- 68
- Headquarters
- Boston, United States
- IPO year
- 2021
- Market cap
- $34.1M
- Website
- https://www.akiliinteractive.com
Loading AKLI…
Loading profile data…Frequently asked questions about AKLI
What does Akili, Inc. (AKLI) do?
Akili, Inc. is a digital medicine enterprise focused on developing innovative digital therapies for individuals experiencing cognitive impairments. Its flagship product, EndeavorRx, stands out as a unique video game-based treatment that necessitates a physician's prescription and is specifically engineered to directly target and improve cognitiv...
Where does AKLI trade?
Akili, Inc. (AKLI) trades on the NASDAQ Capital Market.
What sector is AKLI in?
Akili, Inc. (AKLI) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of Akili, Inc.?
Matthew Franklin is the chief executive officer of Akili, Inc. (AKLI).
Where is Akili, Inc. headquartered?
Akili, Inc. is headquartered in United States.
Does AKLI pay a dividend?
Akili, Inc. (AKLI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AKLI go public?
Akili, Inc. (AKLI) completed its initial public offering in 2021.